5 Stocks Investors Are Watching

In this article, we will look at the 5 Stocks Investors Are Watching. For a deeper discussion and an extended list, please see 10 Stocks Investors Are Watching.

Photo by Tima Miroshnichenko on Pexels

5. BridgeBio Pharma Inc. (NASDAQ:BBIO)

BridgeBio saw its share prices jump by 13.22 percent on Tuesday to close at $74.32 apiece, as investors took path from an investment firm’s double-digit price target upgrade for its stock.

In a market report, JPMorgan raised its price target for BridgeBio Pharma Inc. (NASDAQ:BBIO) to $94 from $89 previously, marking a 26 percent upside potential from its latest closing price. It also maintained an “overweight” rating for the stock.

The coverage came amid BridgeBio Pharma Inc.’s (NASDAQ:BBIO) presentation of additional data on the third phase of its clinical trial for BBP-418 in patients with limb-girdle muscular dystrophy type 2I/R9 (LGMD2I/R9), at the MDA Clinical and Scientific Conference in Orlando, Florida on the same day.

According to the company, BBP-418 demonstrated a statistically significant and clinically meaningful 2.6-point improvement in North Star for Dysferlinopathy (NSAD) versus the placebo. NSAD is a clinician-reported outcome measure (ClinRO) of motor performance initially developed and designed for use in the said disease.

The company said that it was recommended by the Food and Drug Administration to pursue traditional approval for the therapy candidate.

BridgeBio Pharma Inc. (NASDAQ:BBIO) is targeting to submit a new drug application in the first half of the year, and officially launch the therapy late this year or in early 2027.